TOP TIERMARKET NEWSWIRE
News & sentiment

SAREPTA THERAPEUTICS (SRPT) — News & AI sentiment

SAREPTA THERAPEUTICS (SRPT) news roundup. 2 stories in the past week, 10 over 30 days. Average 30-day sentiment is 53.3/100. No insider transactions filed in the last 90 days. US House Periodic Transaction Reports (90-day window): 0 purchases (~$0) and 2 sales (~$65K). Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
2
avg sentiment 51/100
30d stories
10
avg sentiment 53.3/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
-2
0 buys · 2 sells

SRPT news in the last 24 hours, 7 days, 30 days and 90 days

How much SRPT coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowSRPT storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days251/100SRPT headlines →
Last 30 days1053.3/100SRPT headlines →
Last 90 days4149.5/100SRPT headlines →

Latest stories on SRPT

2d ago
6d ago
Oct 14
Oct 14
Oct 12
Oct 8
Sep 30
Sep 30
Sep 30
Sep 30
Sep 25
Sep 24
Sep 24
Sep 23
Sep 23
Sep 15
Sep 14
Sep 9
H.C. Wainwright reiterates Sarepta stock Sell rating at $5 target
Investing.com Analyst Ratings28 · bearishanalyst
Sep 9
Sep 8
Sep 8
Sep 8
Sep 8
Sep 8
Mizuho reiterates Sarepta stock rating after Novartis trial miss
Investing.com Analyst Ratings38 · neutralanalyst
Sep 8
Open SRPT in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →